Monument Capital Management decreased its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 4.4% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 1,639 shares of the semiconductor company’s stock after selling 75 shares during the quarter. Monument Capital Management’s holdings in Synopsys were worth $796,000 at the end of the most recent reporting period.
Several other institutional investors have also recently added to or reduced their stakes in SNPS. Davidson Capital Management Inc. raised its position in shares of Synopsys by 33,828.6% in the third quarter. Davidson Capital Management Inc. now owns 4,750 shares of the semiconductor company’s stock valued at $2,405,000 after buying an additional 4,736 shares during the last quarter. Peloton Wealth Strategists lifted its stake in shares of Synopsys by 221.2% in the 3rd quarter. Peloton Wealth Strategists now owns 2,881 shares of the semiconductor company’s stock valued at $1,459,000 after purchasing an additional 1,984 shares in the last quarter. Swiss National Bank raised its holdings in Synopsys by 0.7% in the third quarter. Swiss National Bank now owns 454,800 shares of the semiconductor company’s stock valued at $230,306,000 after buying an additional 3,200 shares during the period. Parnassus Investments LLC purchased a new stake in Synopsys during the third quarter worth approximately $633,469,000. Finally, Harvest Portfolios Group Inc. increased its position in shares of Synopsys by 3.7% in the third quarter. Harvest Portfolios Group Inc. now owns 42,121 shares of the semiconductor company’s stock worth $21,330,000 after acquiring an additional 1,496 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Price Performance
SNPS stock opened at $522.53 on Monday. Synopsys, Inc. has a 52-week low of $457.52 and a 52-week high of $629.38. The stock has a market capitalization of $80.77 billion, a price-to-earnings ratio of 35.99, a price-to-earnings-growth ratio of 3.49 and a beta of 1.12. The company has a 50-day moving average of $510.78 and a two-hundred day moving average of $518.00.
Analysts Set New Price Targets
View Our Latest Stock Analysis on Synopsys
Insider Buying and Selling at Synopsys
In related news, CRO Richard S. Mahoney sold 20,838 shares of the stock in a transaction that occurred on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the sale, the executive now directly owns 1,460 shares in the company, valued at $738,774.60. This represents a 93.45 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.66% of the company’s stock.
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading
- Five stocks we like better than Synopsys
- Why Are These Companies Considered Blue Chips?
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- Consumer Discretionary Stocks Explained
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- Health Care Stocks Explained: Why You Might Want to Invest
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.